Latest news
Axsome Therapeutics (AXSM) Q1 2026 Earnings: Wide EPS Miss Triggers 7.1% Selloff - Segment Revenue Breakdown - dars.gov.etdars.gov.et · Sun, 02 Aug 2026 23:43:33 GMTZYME Q1 2026 Earnings: Wide EPS Miss Triggers 3.54% Share Decline - Revenue Estimate Trend - dars.gov.etdars.gov.et · Fri, 31 Jul 2026 07:00:00 GMTMicron Revenues Could Triple Again By 2030. Here’s the Math. - 24/7 Wall St.24/7 Wall St. · Wed, 29 Jul 2026 07:00:00 GMTXOMA Q1 2026 Earnings: Royalty Revenue Gap Triggers Wide EPS Miss - Return On Assets - dars.gov.etdars.gov.et · Wed, 29 Jul 2026 07:00:00 GMTXOMA Q1 2026 Earnings: Royalty Revenue Gap Triggers Wide EPS Miss - EBITDA Margin Trends - dars.gov.etdars.gov.et · Wed, 29 Jul 2026 07:00:00 GMT